StockTipsArenaBeta

BUY Biocon Ltd — Prashant P. Sawant

BUYBiocon Ltd
Biocon share price target & all analyst calls

byPrashant P. SawantHorizon: NA (inferred Intraday)12 Aug 2026, 9:26 am ISTvia CNBC Awaaz.

Entry₹425Inferred
Target₹445
Total upside +4.71% (call closed)
Stop loss₹419-1.41% risk
At expiry₹427.412 Aug 2026, 3:05 pm
Expired+0.56%
Follow Prashant P. Sawant for new calls(5% target hit, 19 closed calls)Get alertsWatch BIOCON for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 12 Aug 2026
5 supporting2 neutral0 opposing
Supports the BUY call (5)

3 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·12 Aug · today

Biocon Shares Surge Nearly 3% After Q1 Profit Jumps 350%

NewsNdtv-Profit·6 Aug · 6d ago

(opens in new tab)

Biocon Q1 Results: Profit Spikes 350%, Revenue Exceeds Rs 4,300 Crore

NewsNdtv-Profit·5 Aug · 6d ago

(opens in new tab)

Biocon Q1 Results: Net profit jumps over four-fold as biopharma business drives growth

NewsCnbc-Tv18·5 Aug · 6d ago

(opens in new tab)

Biocon Q1FY27 Total Income at Rs 4,391 Cr (up 9%), EBITDA at Rs 902 Cr, Net Profit at Rs 141 Cr, with Biopharma Revenue up 17%.

NSE · Press Release·5 Aug · 6d ago

(opens in new tab)
Neutral / worth noting (2)

From profit surges to margin worries: The big takeaways from Wednesday's earnings

NewsCnbc-Tv18·5 Aug · 6d ago

(opens in new tab)

Biocon Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·5 Aug · 6d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Biocon

All analyst calls on Biocon

More from Prashant P. Sawant

Every call and its outcome